Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Superb. Few extracts.
'If you have diabetes you have to have a test for kidney disease. You need to know. Whether it's a low risk, a medium risk or a high risk, you need to know. Because if you have chronic kidney disease there are drugs that can manage and reduce deterioration'...
'We are entering a new paradigm once we have lcd coverage'.
'Everybody wins- the insurance industry wins because they are saving the very expensive costs of dialysis, the government wins...the economy wins, patients and would be patients win... we win'.
'I can not see a reason why a health care insurer would not want to know the risk of the customer. This is the solution to managing preventative approaches to kidney disease. The adverse consequences are already evident.'
'We are working on educating physicians alongside big pharma'.
'I think we're in a win-win situation'.
' We should be looking at getting lcd coverage by September or sooner'
'the margin on $950 is very significant'
'A final LCD means we can service the entire Medicare population with kidneylx'.
Pretty much as regular posters here have noted. They're extending their sales team so that they can go it alone- at the same time they are now in discussions with multiple potential acquirers- not just those in the diagnostics industry.
Looks like they will have sold before too long to me, if they get a fair price. They won't sell for peanuts. They're clearly very ambitious. They will get sales going substantially first imho- make it hard for big pharma to push them around. They are now talking about a serious strategic approach to sales. Looking at 2 options (very much as I have suggested on this board)- building sales themselves or getting bought out. They also recognise that building sales in key states with high demand will ensure any takeover is competitive and adds value for shareholders. I like the CEO. Maybe it's the American accent ;)
Many thanks for the feedback great stuff
I agree with Tricky. They're hedging their bets with the sales pipeline to ensure they get a fair price. I don't see them going alone long term as it will be hard for them to get major traction as a little fish.
My 10c worth, LCD by Sep. Firm offer by end Q4.
All very positive!
Anyone care to speculate on offer price per share that they would accept??
Buddha Bob. OK I will play. I am saying £2.00. I will accept more though😅
I was thinking £2 to £3 range.
I'd also take more if required 😆
10 bagger, will do me.
If a proposal of £2/share (or about £300m) was being considered….what do you think the share price would currently be? (Surely atleast £1?)
I would like to be proven wrong, but I would not be surprised if the bids are currently 50p-£1.
Jatw- Market capitalisation does not translate into a company's valuation. The current share price has very little to do with what the company is actually worth.
A sale price would be based on a valuation of the company to include IP, assets, debts, etc etc. This is why they're probably currently going through due diligence under NDA so the potential buyer can properly value RENX before making an offer. Hence why they are also trying to build a sales pipeline to demonstrate market potential.
So the current SP level doesn't have a direct correlation to the price they will offer.
These were nearly £13 a few years ago?
Hard to see anyone buying this when they could wait (a shortish while) until it is in administration.
Scarfell 😆 😆 🤣 😂
Yeah, okay.
Couple of points as doing some searching:
1. Looking at Renalytix website shareholder information, i cannot see a holding for Harwood Capital? Have they completely sold out or am i missing something as they updated us with their latest rns albeit out of date holding on 14 May?
2. Anyone got link to the recent presenation last week?
Thanks in advance for your help
If you think this will go into administration, then the current investors (unless they are also the buyer) will consider the product a failure….and therefore worthless
If you think the product is worth buying out of administration then it is not a failure……
With the regulatory backing and real world data, it seems to me that the product does make a difference and is not likely to be considered a failure, hence the existing investors will keep the business out of administration until a sale at a good price can be achieved. What that is is highly debateable.